CN111466443A - Nutritional milk powder for growth of children - Google Patents
Nutritional milk powder for growth of children Download PDFInfo
- Publication number
- CN111466443A CN111466443A CN202010287982.2A CN202010287982A CN111466443A CN 111466443 A CN111466443 A CN 111466443A CN 202010287982 A CN202010287982 A CN 202010287982A CN 111466443 A CN111466443 A CN 111466443A
- Authority
- CN
- China
- Prior art keywords
- milk powder
- children
- growth
- vitamin
- oligosaccharide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000843 powder Substances 0.000 title claims abstract description 42
- 235000013336 milk Nutrition 0.000 title claims abstract description 34
- 239000008267 milk Substances 0.000 title claims abstract description 34
- 210000004080 milk Anatomy 0.000 title claims abstract description 34
- 235000016709 nutrition Nutrition 0.000 title claims abstract description 9
- 241001134770 Bifidobacterium animalis Species 0.000 claims abstract description 11
- 229940118852 bifidobacterium animalis Drugs 0.000 claims abstract description 11
- MBMBGCFOFBJSGT-KUBAVDMBSA-N all-cis-docosa-4,7,10,13,16,19-hexaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 claims abstract description 10
- 101710093543 Probable non-specific lipid-transfer protein Proteins 0.000 claims abstract description 9
- 210000003022 colostrum Anatomy 0.000 claims abstract description 9
- 235000021277 colostrum Nutrition 0.000 claims abstract description 9
- 239000011707 mineral Substances 0.000 claims abstract description 9
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 claims abstract description 8
- 108010001441 Phosphopeptides Proteins 0.000 claims abstract description 8
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 claims abstract description 8
- 239000005018 casein Substances 0.000 claims abstract description 8
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 claims abstract description 8
- 235000021240 caseins Nutrition 0.000 claims abstract description 8
- 229910052500 inorganic mineral Inorganic materials 0.000 claims abstract description 8
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims abstract description 8
- 229940088594 vitamin Drugs 0.000 claims abstract description 8
- 229930003231 vitamin Natural products 0.000 claims abstract description 8
- 235000013343 vitamin Nutrition 0.000 claims abstract description 8
- 239000011782 vitamin Substances 0.000 claims abstract description 8
- FTSSQIKWUOOEGC-RULYVFMPSA-N fructooligosaccharide Chemical compound OC[C@H]1O[C@@](CO)(OC[C@@]2(OC[C@@]3(OC[C@@]4(OC[C@@]5(OC[C@@]6(OC[C@@]7(OC[C@@]8(OC[C@@]9(OC[C@@]%10(OC[C@@]%11(O[C@H]%12O[C@H](CO)[C@@H](O)[C@H](O)[C@H]%12O)O[C@H](CO)[C@@H](O)[C@@H]%11O)O[C@H](CO)[C@@H](O)[C@@H]%10O)O[C@H](CO)[C@@H](O)[C@@H]9O)O[C@H](CO)[C@@H](O)[C@@H]8O)O[C@H](CO)[C@@H](O)[C@@H]7O)O[C@H](CO)[C@@H](O)[C@@H]6O)O[C@H](CO)[C@@H](O)[C@@H]5O)O[C@H](CO)[C@@H](O)[C@@H]4O)O[C@H](CO)[C@@H](O)[C@@H]3O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@@H](O)[C@@H]1O FTSSQIKWUOOEGC-RULYVFMPSA-N 0.000 claims abstract description 7
- 229940107187 fructooligosaccharide Drugs 0.000 claims abstract description 7
- 235000021255 galacto-oligosaccharides Nutrition 0.000 claims abstract description 7
- 150000003271 galactooligosaccharides Chemical class 0.000 claims abstract description 7
- 229940090949 docosahexaenoic acid Drugs 0.000 claims abstract description 5
- 235000020669 docosahexaenoic acid Nutrition 0.000 claims abstract description 5
- 235000012680 lutein Nutrition 0.000 claims abstract description 5
- 229960005375 lutein Drugs 0.000 claims abstract description 5
- 239000001656 lutein Substances 0.000 claims abstract description 5
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 claims abstract description 5
- ORAKUVXRZWMARG-WZLJTJAWSA-N lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C ORAKUVXRZWMARG-WZLJTJAWSA-N 0.000 claims abstract description 5
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 claims abstract description 5
- FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 claims abstract description 5
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 claims abstract description 4
- 229930064664 L-arginine Natural products 0.000 claims abstract description 4
- 235000014852 L-arginine Nutrition 0.000 claims abstract description 4
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 claims abstract description 4
- 229930182844 L-isoleucine Natural products 0.000 claims abstract description 4
- 235000019454 L-leucine Nutrition 0.000 claims abstract description 4
- 239000004395 L-leucine Substances 0.000 claims abstract description 4
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims abstract description 4
- 229940114079 arachidonic acid Drugs 0.000 claims abstract description 4
- 235000021342 arachidonic acid Nutrition 0.000 claims abstract description 4
- 235000012041 food component Nutrition 0.000 claims abstract description 4
- 229960000310 isoleucine Drugs 0.000 claims abstract description 4
- 239000008101 lactose Substances 0.000 claims abstract description 4
- 229960003136 leucine Drugs 0.000 claims abstract description 4
- 229940067631 phospholipid Drugs 0.000 claims abstract description 4
- 150000003904 phospholipids Chemical class 0.000 claims abstract description 4
- 235000020183 skimmed milk Nutrition 0.000 claims abstract description 4
- 229960003080 taurine Drugs 0.000 claims abstract description 4
- 235000008939 whole milk Nutrition 0.000 claims abstract description 4
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 claims description 8
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 8
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 8
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 claims description 8
- 235000010755 mineral Nutrition 0.000 claims description 8
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 claims description 8
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 claims description 7
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 claims description 6
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims description 4
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 claims description 4
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims description 4
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 claims description 4
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 claims description 4
- 229930003451 Vitamin B1 Natural products 0.000 claims description 4
- 229930003268 Vitamin C Natural products 0.000 claims description 4
- 229930003316 Vitamin D Natural products 0.000 claims description 4
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 claims description 4
- 229930003427 Vitamin E Natural products 0.000 claims description 4
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims description 4
- 229960001231 choline Drugs 0.000 claims description 4
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 claims description 4
- 229960000304 folic acid Drugs 0.000 claims description 4
- 235000019152 folic acid Nutrition 0.000 claims description 4
- 239000011724 folic acid Substances 0.000 claims description 4
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 4
- 229960003512 nicotinic acid Drugs 0.000 claims description 4
- 235000001968 nicotinic acid Nutrition 0.000 claims description 4
- 239000011664 nicotinic acid Substances 0.000 claims description 4
- 229940055726 pantothenic acid Drugs 0.000 claims description 4
- 235000019161 pantothenic acid Nutrition 0.000 claims description 4
- 239000011713 pantothenic acid Substances 0.000 claims description 4
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 claims description 4
- 229960003495 thiamine Drugs 0.000 claims description 4
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 claims description 4
- 235000019155 vitamin A Nutrition 0.000 claims description 4
- 239000011719 vitamin A Substances 0.000 claims description 4
- 235000010374 vitamin B1 Nutrition 0.000 claims description 4
- 239000011691 vitamin B1 Substances 0.000 claims description 4
- 235000019158 vitamin B6 Nutrition 0.000 claims description 4
- 239000011726 vitamin B6 Substances 0.000 claims description 4
- 235000019154 vitamin C Nutrition 0.000 claims description 4
- 239000011718 vitamin C Substances 0.000 claims description 4
- 235000019166 vitamin D Nutrition 0.000 claims description 4
- 239000011710 vitamin D Substances 0.000 claims description 4
- 150000003710 vitamin D derivatives Chemical class 0.000 claims description 4
- 235000019165 vitamin E Nutrition 0.000 claims description 4
- 229940046009 vitamin E Drugs 0.000 claims description 4
- 239000011709 vitamin E Substances 0.000 claims description 4
- 229940045997 vitamin a Drugs 0.000 claims description 4
- 229940011671 vitamin b6 Drugs 0.000 claims description 4
- 229940046008 vitamin d Drugs 0.000 claims description 4
- 229910000019 calcium carbonate Inorganic materials 0.000 claims description 3
- 229960003563 calcium carbonate Drugs 0.000 claims description 3
- 239000011706 ferric diphosphate Substances 0.000 claims description 3
- 235000007144 ferric diphosphate Nutrition 0.000 claims description 3
- CADNYOZXMIKYPR-UHFFFAOYSA-B ferric pyrophosphate Chemical compound [Fe+3].[Fe+3].[Fe+3].[Fe+3].[O-]P([O-])(=O)OP([O-])([O-])=O.[O-]P([O-])(=O)OP([O-])([O-])=O.[O-]P([O-])(=O)OP([O-])([O-])=O CADNYOZXMIKYPR-UHFFFAOYSA-B 0.000 claims description 3
- 229940036404 ferric pyrophosphate Drugs 0.000 claims description 3
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 claims description 3
- 229960001763 zinc sulfate Drugs 0.000 claims description 3
- 229910000368 zinc sulfate Inorganic materials 0.000 claims description 3
- 235000008935 nutritious Nutrition 0.000 claims 5
- 239000000126 substance Substances 0.000 abstract description 4
- 238000000034 method Methods 0.000 description 6
- 230000018109 developmental process Effects 0.000 description 4
- 230000009471 action Effects 0.000 description 3
- 230000036039 immunity Effects 0.000 description 3
- 230000035764 nutrition Effects 0.000 description 3
- 239000011573 trace mineral Substances 0.000 description 3
- 235000013619 trace mineral Nutrition 0.000 description 3
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 210000002249 digestive system Anatomy 0.000 description 2
- 210000000987 immune system Anatomy 0.000 description 2
- 208000001491 myopia Diseases 0.000 description 2
- 230000004379 myopia Effects 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 208000002177 Cataract Diseases 0.000 description 1
- 206010058314 Dysplasia Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000004641 brain development Effects 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 210000001525 retina Anatomy 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 239000001052 yellow pigment Substances 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/16—Agglomerating or granulating milk powder; Making instant milk powder; Products obtained thereby
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
- A23C9/1203—Addition of, or treatment with, enzymes or microorganisms other than lactobacteriaceae
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
- A23C9/13—Fermented milk preparations; Treatment using microorganisms or enzymes using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
- A23C9/13—Fermented milk preparations; Treatment using microorganisms or enzymes using additives
- A23C9/1307—Milk products or derivatives; Fruit or vegetable juices; Sugars, sugar alcohols, sweeteners; Oligosaccharides; Organic acids or salts thereof or acidifying agents; Flavours, dyes or pigments; Inert or aerosol gases; Carbonation methods
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
- A23C9/13—Fermented milk preparations; Treatment using microorganisms or enzymes using additives
- A23C9/1315—Non-milk proteins or fats; Seeds, pulses, cereals or soja; Fatty acids, phospholipids, mono- or diglycerides or derivatives therefrom; Egg products
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
- A23C9/13—Fermented milk preparations; Treatment using microorganisms or enzymes using additives
- A23C9/1322—Inorganic compounds; Minerals, including organic salts thereof, oligo-elements; Amino-acids, peptides, protein-hydrolysates or derivatives; Nucleic acids or derivatives; Yeast extract or autolysate; Vitamins; Antibiotics; Bacteriocins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/51—Bifidobacterium
- A23V2400/515—Animalis
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Microbiology (AREA)
- Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Nutrition Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
The invention relates to the technical field of children milk powder, and discloses children growth nutritional milk powder which comprises the following nutritional components of whole milk powder, lactose, skim milk powder, fructo-oligosaccharide, galacto-oligosaccharide, arachidonic acid, docosahexaenoic acid, colostrum basic protein, bifidobacterium animalis Bb-12, casein phosphopeptide, lutein, taurine, phospholipid, L-arginine, L-leucine, D L-isoleucine, mineral substances and vitamins.
Description
Technical Field
The invention relates to the technical field of children milk powder, in particular to children growth nutritional milk powder.
Background
With the development of children and teenagers, the height has certain problems, according to results of ' survey report on the current situation of height management of children's China ', the children with more than five adults are difficult to reach the genetic height, the future height of the children with nearly eight adults cannot reach the expectation of parents, and poor eye use habits lead to the visual dysplasia of the children and the teenagers, so that the myopia rate of the children and the teenagers is high, and simultaneously, with the abuse of modern antibiotics and the infection of some viruses and germs, the physique of the children and the teenagers is reduced.
Disclosure of Invention
Technical problem to be solved
Aiming at the defects of the prior art, the invention provides the children growth nutrition milk powder, and solves the problems in the background technology.
(II) technical scheme
In order to achieve the purpose, the invention provides the following technical scheme that the children growth nutrition milk powder comprises the following nutritional components of whole milk powder, lactose, skimmed milk powder, fructo-oligosaccharide, galacto-oligosaccharide, arachidonic acid, docosahexaenoic acid, colostrum basic protein, bifidobacterium animalis Bb-12, casein phosphopeptide, lutein, taurine, phospholipid, L-arginine, L-leucine, D L-isoleucine, minerals and vitamins.
Preferably, the amount of said colostrum basic protein added per 100g of said milk powder is greater than or equal to 40 mg.
Preferably, the casein phosphopeptide is added in an amount of greater than or equal to 30mg per 100g of the milk powder.
Preferably, the addition amount of the bifidobacterium animalis Bb-12 in every 100g of the milk powder is more than or equal to 1 x 10^8 CFU.
Preferably, the mineral comprises calcium carbonate, ferric pyrophosphate and zinc sulfate.
Preferably, the vitamins include choline, vitamin C, niacin, vitamin E, pantothenic acid, vitamin A, vitamin B1, vitamin B6, folic acid and vitamin D.
(III) advantageous effects
The invention provides nutritional milk powder for children growth, which has the following beneficial effects:
1. compared with the existing commercial children milk powder, the colostrum basic protein is added into the milk powder, so that the growth and development of bones can be promoted, the height of children and teenagers can be improved, and the immunity of a human body can be improved.
2. The lutein is added into the milk powder, so that the eyesight development of children and teenagers can be promoted, the myopia rate is reduced, the retina can be protected, the stimulation of blue light can be resisted, the yellow pigment density is improved, and the cataract is reduced.
3. Bifidobacterium animalis Bb-12, fructo-oligosaccharide and galacto-oligosaccharide are added into the milk powder, the fructo-oligosaccharide and the galacto-oligosaccharide can promote the growth of the Bifidobacterium animalis Bb-12, and the Bifidobacterium animalis Bb-12 can influence the immune system by regulating the digestive system, thereby improving the immunity of a human body.
4. The milk powder is added with docosahexaenoic acid, so that the brain development of children and teenagers can be promoted, and the children and the teenagers can be more clever.
Detailed Description
The technical solutions in the embodiments of the present invention will be clearly and completely described below with reference to the embodiments of the present invention, and it is obvious that the described embodiments are only a part of the embodiments of the present invention, and not all of the embodiments. All other embodiments, which can be derived by a person skilled in the art from the embodiments given herein without making any creative effort, shall fall within the protection scope of the present invention.
The invention provides a technical scheme that the children growth nutrition milk powder is characterized by comprising the following nutritional components of whole milk powder, lactose, skimmed milk powder, fructo-oligosaccharide, galacto-oligosaccharide, arachidonic acid, docosahexaenoic acid, colostrum basic protein, bifidobacterium animalis Bb-12, casein phosphopeptide, lutein, taurine, phospholipid, L-arginine, L-leucine, D L-isoleucine, mineral substances and vitamins.
Furthermore, the addition amount of colostrum basic protein in every 100g of milk powder is more than or equal to 40mg, and the colostrum basic protein can promote the growth and development of bones, so that the height of children and teenagers can be improved, and the immunity of a human body can also be improved.
Furthermore, the addition amount of the casein phosphopeptide in every 100g of milk powder is more than or equal to 30mg, and the casein phosphopeptide can effectively promote the absorption and utilization of divalent mineral nutrients such as calcium, iron, zinc and the like by a human body.
Furthermore, the addition amount of the bifidobacterium animalis Bb-12 in every 100g of milk powder is more than or equal to 1 x 10 < Lambda > 8CFU, and the mutual matching of the bifidobacterium animalis Bb-12, fructo-oligosaccharide and galacto-oligosaccharide can regulate the digestive system, thereby influencing the immune system and further improving the immune capability of a human body.
Furthermore, the mineral substance comprises calcium carbonate, ferric pyrophosphate and zinc sulfate, and trace elements in the mineral substance can supplement trace elements in the body in time, so that the disease caused by the lack of trace elements in the body is avoided.
Furthermore, the vitamins comprise choline, vitamin C, nicotinic acid, vitamin E, pantothenic acid, vitamin A, vitamin B1, vitamin B6, folic acid and vitamin D, and the choline, the vitamin C, the nicotinic acid, the vitamin E, the pantothenic acid, the vitamin A, the vitamin B1, the vitamin B6, the folic acid, the vitamin D and other nutrient components in the vitamins can maintain the health of human bodies.
The eating method of the milk powder comprises the following steps: pouring 180 ml of warm boiled water into the cup, adding 3 spoons of milk powder (about 25 g) and stirring until the milk powder is completely dissolved.
The storage method of the milk powder comprises the following steps: the product is placed in a cool and dry place to avoid direct irradiation of sunlight, and the product is tightly covered after each use. It is recommended that the food is consumed within 4 weeks after unsealing, and is taken immediately after reconstitution or refrigerated below 4 deg.C and consumed within 2 days.
It is noted that, herein, relational terms such as first and second, and the like may be used solely to distinguish one entity or action from another entity or action without necessarily requiring or implying any actual such relationship or order between such entities or actions. Also, the terms "comprises," "comprising," or any other variation thereof, are intended to cover a non-exclusive inclusion, such that a process, method, article, or apparatus that comprises a list of elements does not include only those elements but may include other elements not expressly listed or inherent to such process, method, article, or apparatus.
Although embodiments of the present invention have been shown and described, it will be appreciated by those skilled in the art that changes, modifications, substitutions and alterations can be made in these embodiments without departing from the principles and spirit of the invention, the scope of which is defined in the appended claims and their equivalents.
Claims (6)
1. A nutritional milk powder for the growth of children is characterized by comprising the following nutritional components of whole milk powder, lactose, skimmed milk powder, fructo-oligosaccharide, galacto-oligosaccharide, arachidonic acid, docosahexaenoic acid, colostrum basic protein, bifidobacterium animalis Bb-12, casein phosphopeptide, lutein, taurine, phospholipid, L-arginine, L-leucine, D L-isoleucine, minerals and vitamins.
2. The children's growth nutritious milk powder as claimed in claim 1, wherein: the addition amount of the colostrum basic protein in every 100g of the milk powder is more than or equal to 40 mg.
3. The children's growth nutritious milk powder as claimed in claim 1, wherein: the addition amount of the casein phosphopeptide in every 100g of the milk powder is more than or equal to 30 mg.
4. The children's growth nutritious milk powder as claimed in claim 1, wherein: the addition amount of the bifidobacterium animalis Bb-12 in every 100g of the milk powder is more than or equal to 1 x 10^8 CFU.
5. The children's growth nutritious milk powder as claimed in claim 1, wherein: the mineral comprises calcium carbonate, ferric pyrophosphate and zinc sulfate.
6. The children's growth nutritious milk powder as claimed in claim 1, wherein: the vitamins include choline, vitamin C, nicotinic acid, vitamin E, pantothenic acid, vitamin A, vitamin B1, vitamin B6, folic acid, and vitamin D.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010287982.2A CN111466443A (en) | 2020-04-14 | 2020-04-14 | Nutritional milk powder for growth of children |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010287982.2A CN111466443A (en) | 2020-04-14 | 2020-04-14 | Nutritional milk powder for growth of children |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN111466443A true CN111466443A (en) | 2020-07-31 |
Family
ID=71752379
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202010287982.2A Pending CN111466443A (en) | 2020-04-14 | 2020-04-14 | Nutritional milk powder for growth of children |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN111466443A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112753776A (en) * | 2021-01-27 | 2021-05-07 | 培臻生物科技(上海)有限公司 | Milk powder for protecting intestines and stomach and preparation method thereof |
| CN113455547A (en) * | 2021-07-07 | 2021-10-01 | 林光华 | Formula milk powder for promoting growth and development of children and preparation method thereof |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101911976A (en) * | 2010-07-30 | 2010-12-15 | 生命阳光(广州)营养品有限公司 | Milk calcium formula nutritional powder |
| CN105724584A (en) * | 2016-03-14 | 2016-07-06 | 上海晨冠乳业有限公司 | Infant formula milk powder with prebiotics and probiotics and method for preparing infant formula milk powder |
-
2020
- 2020-04-14 CN CN202010287982.2A patent/CN111466443A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101911976A (en) * | 2010-07-30 | 2010-12-15 | 生命阳光(广州)营养品有限公司 | Milk calcium formula nutritional powder |
| CN105724584A (en) * | 2016-03-14 | 2016-07-06 | 上海晨冠乳业有限公司 | Infant formula milk powder with prebiotics and probiotics and method for preparing infant formula milk powder |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112753776A (en) * | 2021-01-27 | 2021-05-07 | 培臻生物科技(上海)有限公司 | Milk powder for protecting intestines and stomach and preparation method thereof |
| CN113455547A (en) * | 2021-07-07 | 2021-10-01 | 林光华 | Formula milk powder for promoting growth and development of children and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN100391353C (en) | Formula milk powder for babies | |
| CN103053695B (en) | Female formula goat milk powder and preparation method thereof | |
| JP5615285B2 (en) | Composition for preventing or treating anemia | |
| CN103070241A (en) | Infant-formula goat milk powder of pure goat milk protein and preparation method thereof | |
| SG174355A1 (en) | Improvement in promotion of healthy catch-up growth | |
| RU2549709C1 (en) | Probiotic sour cream production method | |
| CN111466443A (en) | Nutritional milk powder for growth of children | |
| CN107319528A (en) | A kind of intelligence development cerebrum tonifying infant nutrient packs agent | |
| CN111264623A (en) | Milk powder for promoting growth and development of children and preparation method thereof | |
| CN103844029A (en) | Piglet creep feed capable of reducing diarrhea | |
| CN106819125B (en) | Dairy product and method for producing the same | |
| CN103070242A (en) | Formula goat milk powder for pregnant women and preparation method of formula goat milk powder | |
| CN113396983A (en) | Child modified milk powder rich in comprehensive nutrition and preparation method thereof | |
| CN105076418A (en) | Infant formula milk powder for promoting development of brain nerves and gastrointestinal tissues of infants | |
| US20160366916A1 (en) | Formula for management of phenylketonuria | |
| CN108813632A (en) | A kind of alimentation composition and its application containing lactoferrin | |
| CN105746713A (en) | Infant formula milk powder capable of promoting development of intestinal mucosal immunity function of newborn | |
| CN112868803A (en) | Formula milk powder for improving breast milk nutrition and preparation method thereof | |
| CN107927198A (en) | One kind drinks milk powder and preparation method thereof for premature | |
| CN112219901A (en) | Dairy product for promoting sleep and preparation method thereof | |
| CN111642566A (en) | Goat milk powder beneficial to children's height and intelligence development | |
| CN101564174B (en) | Protein powder corrected by humanized amino acid spectrum | |
| JPH1014534A (en) | Nutritive composition | |
| WO2017030330A1 (en) | Liquid infant formula composition containing goat milk | |
| KR102050578B1 (en) | Composition of infant liquid formula including goat milk |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20200731 |
|
| RJ01 | Rejection of invention patent application after publication |